Reuters: Health
India's Strides Pharma Science Ltd said on Friday it has halted sales of its heartburn drug Ranitidine in the U.S. market as it conducts tests to identify possible cancer-causing impurities in the tablets.
India's Strides Pharma halts U.S. sales of heartburn drug
India's Strides Pharma halts U.S. sales of heartburn drug
Reuters: Health
India's Strides Pharma Science Ltd said on Friday it has halted sales of its heartburn drug Ranitidine in the U.S. market as it conducts tests to identify possible cancer-causing impurities in the tablets.
Reuters: Health
India's Strides Pharma Science Ltd said on Friday it has halted sales of its heartburn drug Ranitidine in the U.S. market as it conducts tests to identify possible cancer-causing impurities in the tablets.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment